Sage Therapeutics, Inc. Shareholders' Equity
Sage Therapeutics, Inc. had Shareholders' Equity of $368.74 million as of 2025-06-30, per its 10-Q filed 2025-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-07-30
- 2025-06-30: Stockholders' Equity Attributable to Parent $368.74M.
- 2025-03-31: Stockholders' Equity Attributable to Parent $409.85M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $465.09M.
- 2024-09-30: Stockholders' Equity Attributable to Parent $551.84M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-06-30 | $368.74M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $409.85M 10-Q · filed 2025-07-30 |
| 2024-12-31 | $465.09M 10-Q · filed 2025-07-30 |
| 2024-09-30 | $551.84M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $628.06M 10-Q · filed 2025-07-30 |
| 2024-03-31 | $705.80M 10-Q · filed 2025-07-30 |
| 2023-12-31 | $799.53M 10-Q · filed 2025-07-30 |
| 2023-09-30 | $816.66M 10-Q · filed 2024-10-29 |
| 2023-06-30 | $984.38M 10-Q · filed 2024-10-29 |
| 2023-03-31 | $1.13B 10-Q · filed 2024-10-29 |
| 2022-12-31 | $1.25B 10-K · filed 2025-02-11 |
| 2022-09-30 | $1.38B 10-Q · filed 2023-11-07 |
| 2022-06-30 | $1.50B 10-Q · filed 2023-11-07 |
| 2022-03-31 | $1.62B 10-Q · filed 2023-11-07 |
| 2021-12-31 | $1.73B 10-K · filed 2025-02-11 |
| 2021-09-30 | $1.84B 10-Q · filed 2022-11-08 |
| 2021-06-30 | $1.93B 10-Q · filed 2022-11-08 |
| 2021-03-31 | $2.00B 10-Q · filed 2022-11-08 |
| 2020-12-31 | $2.07B 10-K · filed 2024-02-14 |
| 2020-09-30 | $657.58M 10-Q · filed 2021-11-02 |
| 2020-06-30 | $739.91M 10-Q · filed 2021-11-02 |
| 2020-03-31 | $849.21M 10-Q · filed 2021-11-02 |
| 2019-12-31 | $944.65M 10-K · filed 2023-02-16 |
| 2019-09-30 | $1.08B 10-Q · filed 2020-11-05 |
| 2019-06-30 | $1.20B 10-Q · filed 2020-11-05 |
| 2019-03-31 | $1.32B 10-Q · filed 2020-11-05 |
| 2018-12-31 | $862.97M 10-K · filed 2022-02-24 |
| 2018-09-30 | $988.50M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $1.08B 10-Q · filed 2019-11-12 |
| 2018-03-31 | $1.06B 10-Q · filed 2019-11-12 |
| 2017-12-31 | $475.48M 10-K · filed 2021-02-24 |
| 2017-09-30 | $200.05M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $260.30M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $318.45M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $368.52M 10-K · filed 2020-02-27 |
| 2016-09-30 | $413.74M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $257.21M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $287.50M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $173.69M 10-K · filed 2019-02-19 |
| 2015-09-30 | $198.10M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $217.45M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $106.51M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $121.89M 10-K · filed 2018-02-22 |
| 2014-09-30 | $132.92M 10-Q · filed 2014-11-13 |
| 2014-06-30 | -$44.79M 10-Q · filed 2014-08-14 |
| 2013-12-31 | -$31.54M 10-K · filed 2017-02-24 |
| 2012-12-31 | -$13.39M 10-K · filed 2016-02-29 |
| 2011-12-31 | -$3.76M 10-K · filed 2015-03-06 |